Literature DB >> 24649049

Bone morphogenetic protein 7 upregulates the expression of nestin and glial fibrillary acidic protein in rats with cerebral ischemia-reperfusion injury.

Rui Zhang1, Haitao Pei2, Lijuan Ru2, Hongyun Li2, Guangyi Liu1.   

Abstract

Bone morphogenetic protein 7 (BMP7) is a member of the transforming growth factor-β (TGF-β) superfamily and was initially identified as a protein that may induce bone and cartilage growth in the bone matrix. The present study was conducted in order to investigate the effect of BMP7 on the expression of nestin and glial fibrillary acidic protein (GFAP) in the brain tissue of rats after cerebral ischemia-reperfusion injury. A total of 40 adult healthy male Sprague-Dawley rats were used in this study, of which 10 randomly received a sham operation and the remaining 30 were subjected to a 2-h ischemia and 24-h reperfusion by ligation of the left external and internal carotid arteries. Twenty successfully modeled rats were equally randomized into the treatment and control groups. The rats in the treatment group were intervened with 250 μl BMP7 (0.1 mg/kg) via tail vein injection, whereas the rats in the control and sham operation groups were injected with an equal volume of sterile water for injection. Neurological deficits were evaluated by the Bederson's method at 24 h after ischemia-reperfusion and the brain infarct volume was assessed by 2,3,5-triphenyl tetrazolium chloride coloring. The neuronal apoptosis was assessed by terminal deoxynucleotidyl transferase-mediated biotinylated deoxyuridine triphosphate nick end-labelling (TUNEL) staining and the expression of nestin and GFAP in the three groups was analyzed by immunohistochemistry. Bederson's score (t=4.66, P<0.01) and focus infarction (t=6.98, P<0.01) were lower in the BMP7 treatment group compared to those in the control group. In addition, the number of TUNEL-positive cells in the treatment group was lower compared to that in the control group (P<0.01). Compared to the control group, the expression of nestin and GFAP was enhanced in the BMP7 treatment group (P<0.01). Therefore, BMP7 may upregulate the expression of nestin and GFAP and promote neural regeneration to protect animals against ischemia-reperfusion injury.

Entities:  

Keywords:  bone morphogenetic protein 7; cerebral ischemia-reperfusion injury; glial fibrillary acidic protein; nestin; rats

Year:  2013        PMID: 24649049      PMCID: PMC3917014          DOI: 10.3892/br.2013.164

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  17 in total

1.  Re-evaluation of nestin as a marker of oligodendrocyte lineage cells.

Authors:  G Almazán; J M Vela; E Molina-Holgado; C Guaza
Journal:  Microsc Res Tech       Date:  2001-03-15       Impact factor: 2.769

2.  BMP receptor 1b is required for axon guidance and cell survival in the developing retina.

Authors:  Janice Liu; Steven Wilson; Thomas Reh
Journal:  Dev Biol       Date:  2003-04-01       Impact factor: 3.582

3.  Genetic analyses demonstrate that bone morphogenetic protein signaling is required for embryonic cerebellar development.

Authors:  Lihua Qin; Lara Wine-Lee; Kyung J Ahn; E Bryan Crenshaw
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

4.  Osteogenic protein-1 induces dendritic growth in rat sympathetic neurons.

Authors:  P Lein; M Johnson; X Guo; D Rueger; D Higgins
Journal:  Neuron       Date:  1995-09       Impact factor: 17.173

5.  High susceptibility to cerebral ischemia in GFAP-null mice.

Authors:  H Nawashiro; M Brenner; S Fukui; K Shima; J M Hallenbeck
Journal:  J Cereb Blood Flow Metab       Date:  2000-07       Impact factor: 6.200

6.  Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain.

Authors:  D Liu; C L Smith; F C Barone; J A Ellison; P G Lysko; K Li; I A Simpson
Journal:  Brain Res Mol Brain Res       Date:  1999-05-07

7.  Ependymal/subventricular zone cells migrate to the peri-infarct region and differentiate into neurons and astrocytes after focal cerebral ischemia in adult rats.

Authors:  Peng-bo Zhang; Yong Liu; Jie Li; Qian-yan Kang; Ying-fang Tian; Xin-lin Chen; Jian-jun Zhao; Qin-dong Shi; Tu-sheng Song; Yi-hua Qian
Journal:  Di Yi Jun Yi Da Xue Xue Bao       Date:  2005-10

Review 8.  Repairing brain after stroke: a review on post-ischemic neurogenesis.

Authors:  Charles Wiltrout; Bradley Lang; Yiping Yan; Robert J Dempsey; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2007-05-04       Impact factor: 3.921

9.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

10.  Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals.

Authors:  Hui-Ling Chen; Pamela J Lein; Jia-Yi Wang; Don Gash; Barry J Hoffer; Yung-Hsiao Chiang
Journal:  Brain Res       Date:  2003-12-19       Impact factor: 3.252

View more
  2 in total

1.  Bone morphogenetic protein 9 serves a protective role in response to ischemic‑reperfusion in the brain by promoting ERK activation.

Authors:  Yinling Feng; Yida Hu
Journal:  Mol Med Rep       Date:  2017-12-11       Impact factor: 2.952

2.  Local injection of bone morphogenetic protein 7 promotes neuronal regeneration and motor function recovery after acute spinal cord injury.

Authors:  Chen Chen; Guang-Chao Bai; Hong-Liang Jin; Kun Lei; Kuan-Xin Li
Journal:  Neural Regen Res       Date:  2018-06       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.